Zum Inhalt springen

Alzheimer: Leqembi approved in the United Arab Emirates

BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved Leqembi® (lecanemab) for the treatment of Alzheimer’s disease (AD). Treatment with Leqembi should be initiated in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively referred to as early AD), the population in which treatment was initiated in clinical trials. Leqembi’s approval in the UAE is based on the large global Phase 3 Clarity AD study. In the Clarity AD study, Leqembi met its primary endpoint and all key secondary endpoints with statistically significant results.[1] In the UAE, it is reported that 4.09% of those over 60 years old have dementia.[2] AD is considered the most common cause of dementia, typically accounting for 60-70% of cases.[3] Leqembi selectively binds to… 

more »Alzheimer: Leqembi approved in the United Arab Emirates

Pre-Surgical Antibody Treatment Might Prevent Heart Transplant Rejection

A new study from scientists at Cincinnati Children’s suggests there may be a way to further protect transplanted hearts from rejection by preparing the donor organ and the recipient with an anti-inflammatory antibody treatment before surgery occurs. The findings, published online in PNAS, focus on blocking an innate immune response that normally occurs in response to microbial infections. The same response has been shown to drive dangerous inflammation in transplanted hearts. In the new study – in mice — transplanted hearts functioned for longer periods when the organ recipients also received the novel antibody treatment. Now the first of a complex series of steps has begun to determine whether a similar approach can be safely performed for human heart transplants. „The anti-rejection regimens currently in use are broad immunosuppressive agents that make the patients susceptible to infections. By using specific… 

more »Pre-Surgical Antibody Treatment Might Prevent Heart Transplant Rejection
Covid-19 Watch-Eagle. Credits: LabNewsMedia LLC.

Economic and Scientific Differences Between Elon Musk and Donald Trump

Analyzing the Economic and Scientific Differences Between Elon Musk and Donald Trump Through Their Companies. Elon Musk and Donald Trump are both prominent figures in the business world, known for their entrepreneurial ventures and significant impacts on various industries. However, their approaches to business, the nature of their companies, and their economic philosophies differ substantially. This analysis explores these differences by examining the companies they lead and the industries they influence. Elon Musk’s Companies: Innovation and Technology Elon Musk is renowned for his involvement in high-tech and innovative companies. His portfolio includes: – Tesla, Inc.: A leader in electric vehicles and renewable energy solutions. Tesla has revolutionized the automotive industry with its focus on electric cars, battery storage, and sustainable energy solutions. The company’s valuation reached $770.2 billion as of August 2023[3].  – SpaceX: A private aerospace manufacturer and space… 

more »Economic and Scientific Differences Between Elon Musk and Donald Trump

Mutations in the STAG2 Protein Can Cause Leukemia

Researchers at the Leibniz Institute for Immunotherapy (LIT) studied hundreds of patients with acute myeloid leukemia (AML). They discovered that specific mutations in the STAG2 protein cause altered DNA folding in the cell nucleus, thereby contributing to the development of AML. In collaboration with Prof. Ruud Delwel of the Erasmus Medical Center in Rotterdam, the researchers examined changes in the spatial DNA structure in AML patient samples with and without cohesin mutations. They found that mutations in STAG2 lead to alterations in the DNA structure in AML cells. These changes impair normal gene regulation, resulting in certain genes being either overly activated or not activated at all. What is particularly remarkable about this discovery is that these disturbances cannot be compensated for by the STAG1 protein, highlighting the role of STAG2 in AML.In a further step, the researchers examined hematopoietic… 

more »Mutations in the STAG2 Protein Can Cause Leukemia

Fortschritte im Kampf gegen das Hodgkin-Lymphom

Die Abteilung für Lymphome am Krebsinstitut und -krankenhaus der Tianjin Medical University hat in der angesehenen Fachzeitschrift Cancer Biology & Medicine ein umfassendes Update zu HL-Behandlungen veröffentlicht . Die am 29. Dezember 2023 veröffentlichte Studie (DOI: 10.20892/j.issn.2095-3941.2023.0427) untersucht die neuesten Fortschritte bei HL-Therapieschemata und ist ein Hoffnungsschimmer für die medizinische Gemeinschaft und Patienten gleichermaßen. Beim Hodgkin-Lymphom (HL), das die Lymphknoten und das Lymphsystem befällt, haben sich die Überlebensraten dank moderner Chemotherapie allmählich erhöht. Für Patienten, die Resistenzen gegen die Erstbehandlung zeigen oder Rückfälle erleiden, bestehen jedoch weiterhin Herausforderungen, was den dringenden Bedarf an wirksameren therapeutischen Lösungen unterstreicht. Die Feinheiten der Behandlung der Krankheit im Frühstadium gegenüber dem fortgeschrittenen Stadium erfordern darüber hinaus einen differenzierten Behandlungsansatz, der diese Komplexitäten wirksam bewältigen kann. https://www.cancerbiomed.org/content/21/4/269

Baxter Sells Vantive Kidney Care Segment to Carlyle for $3.8 Billion

Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion. Carlyle has been a leading private equity investor in the medtech sector over the past decade, with investments in medical technology and diagnostic companies totaling over $40 billion in enterprise value. Moreover, Carlyle’s investment in Vantive is made in partnership with Atmas Health, a collaboration among three industry executives founded in September 2022 to focus on acquiring and building a market-leading healthcare business. The partnership, consisting of Kieran Gallahue, Jim Hinrichs, and Jim Prutow, brings a proven track record of creating value in the medical technology industry. https://www.baxter.com/baxter-newsroom/baxter-announces-definitive-agreement-divest-its-vantive-kidney-care-segment

Gewalt in Praxen: Lauterbach kündigt Strafverschärfung an

Die niedergelassenen Ärzte haben wegen zunehmender Gewalt von Patienten einen Hilferuf an die Politik adressiert – Bundesgesundheitsminister Karl Lauterbach (SPD) kündigt nun Strafverschärfungen an. Gewalt und Gewaltandrohungen gegen Ärzte und Pflegekräfte müssten stärker bestraft werden, sagte Lauterbach am Dienstag. „Uns droht so schon ein ganz massiver Arztmangel, Praxen können nicht wieder besetzt werden.“ Man arbeite […] Gewalt in Praxen: Lauterbach kündigt Strafverschärfung an

Common lab tests aren’t reliable for diagnosing Long COVID

A new study found that most routine laboratory tests are not reliable for diagnosing Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC). The study, published today in Annals of Internal Medicine, found no reliable biomarker among 25 routine clinical laboratory values for prior infection, PASC or specific types of PASC clusters. This suggests none of these routine labs can serve as a clinically useful biomarker of PASC. „Our study shows patients can have severe Long COVID with normal lab results. This suggests doctors should not focus on the results of blood panels to diagnose Long COVID but should focus more on symptoms and ways to help patients get relief by treating their symptoms,“ said the study’s first author, Kristine Erlandson, MD, a professor in the Division of Infectious Diseases at the University of Colorado Anschutz Medical Campus.… 

more »Common lab tests aren’t reliable for diagnosing Long COVID

Chinese Medical Journal study evaluates embryo using an artificial intelligence model

Infertility affects one in six couples and has a negative impact on their quality of life. Consequently, specialized assisted reproductive technology like in vitro fertilization (IVF) are much sought after. This expensive medical procedure conventionally relies on the evaluation of in vitro-fertilized eggs or embryos, and selecting the best to improve chances of implantation in the uterus. Embryo selection is challenging as it relies on subjective visual inspection of embryo morphology, making the data  highly variable and dependent on physician’s experience. To address this concern, Dr. Kang Zhang from Wenzhou Medical University, Dr Ling Sun from Guangzhou Women and Children Hospital, along with their collaborators in China, developed an artificial intelligence (AI)-based system to automate embryo selection and eliminate subjectivity at this crucial stage. This study, published online in the Chinese Medical Journal on July 12, 2024, describes the automated… 

more »Chinese Medical Journal study evaluates embryo using an artificial intelligence model

Caring Contacts geben suizidgefährdeten Jugendlichen das Gefühl, nach der Entlassung unterstützt zu werden

Während die psychische Gesundheitskrise bei jungen Menschen in den USA anhält, suchen die Anbieter weiterhin nach Möglichkeiten, Lücken in der Versorgung zu schließen. Patienten, die wegen Selbstmordgedanken und -verhalten behandelt werden, benötigen nach ihrer Entlassung aus der stationären Behandlung oder der Notaufnahme zusätzliche Unterstützung in der Übergangsphase. Caring Contacts sind validierende Nachrichten, die Patienten per SMS, Postkarte oder Brief zugesandt werden, um ihnen fortlaufende Betreuung und Unterstützung anzubieten, ohne dass irgendwelche Anforderungen gestellt werden (wie etwa Erinnerungen an den nächsten Termin). Bei Nationwide Children’s wurde Caring Contacts in einem textbasierten Format als Teil der Qualitätsverbesserungsarbeit des Krankenhauses „Zero Suicide“ implementiert. „Zero Suicide“ ist ein Rahmenwerk bewährter Verfahren in der Suizidvorsorge, das nachweislich die Zahl der Suizide in Gesundheitssystemen senkt und Elemente wie routinemäßige Patientenuntersuchungen auf Suizidrisiko umfasst, gefolgt von einer evidenzbasierten Beurteilung und einem Sicherheitsplan, wenn die Patienten positiv getestet… 

more »Caring Contacts geben suizidgefährdeten Jugendlichen das Gefühl, nach der Entlassung unterstützt zu werden